Skip to main
HR

HR Stock Forecast & Price Target

HR Analyst Ratings

Based on 8 analyst ratings
Hold
Strong Buy 13%
Buy 25%
Hold 63%
Sell 0%
Strong Sell 0%

Bulls say

Healthcare Realty Trust Inc. is strategically positioned to deliver attractive funds from operations (FFO) growth, supported by an expanding trend in medical office buildings (MOB), which are projected to generate organic growth exceeding 3% going forward. The company's strategic review and subsequent investments aim to enhance portfolio quality, with a plan to allocate $300 million towards improving properties that account for 13% of net operating income (NOI). Additionally, the increasing demand for outpatient services amidst technological advancements, combined with stable rent growth trends, reinforces a positive long-term outlook for the company’s financial performance.

Bears say

Healthcare Realty Trust Inc. has experienced a notable decline in its IFRS NAVPU, which fell by 6% to $17.74, indicating deteriorating asset values and disappointing rental performance driven by higher concessions. Projections for the company's FFOPU and AFFOPU have been revised downward, now estimated at $1.01 and $0.92 respectively, which are 10%-20% below prior consensus, reflecting anticipated negative growth of 4%-8% in the coming years. Additionally, the implementation of Medicaid cuts under the One Big Beautiful Bill Act (OBBA) may exert further pressure on health systems' profitability, potentially prompting tenants to reconsider their commitments and further impacting revenue stability.

HR has been analyzed by 8 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 25% recommend Buy, 63% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Healthcare Realty Trust Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Healthcare Realty Trust Inc (HR) Forecast

Analysts have given HR a Hold based on their latest research and market trends.

According to 8 analysts, HR has a Hold consensus rating as of Feb 19, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $18.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $18.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Healthcare Realty Trust Inc (HR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.